Related Experiment Videos
Phospholipase A2 isoforms in acute pancreatitis.
H Friess1, S Shrikhande, E Riesle
1Department of Visceral and Transplantation Surgery, University of Bern, Switzerland.
Annals of Surgery
|February 15, 2001
Summary
Phospholipase A2-II and A2-IV (phospholipase A2 isoforms) are upregulated in acute pancreatitis, suggesting they modulate pancreatic inflammation. The pancreas itself appears to be a source of these inflammatory mediators.
Area of Science:
- Gastroenterology
- Molecular Biology
- Inflammation Research
Background:
- Phospholipase A2 (PLA2) enzymes play critical roles in inflammatory processes.
- Understanding PLA2 isoform involvement in pancreatitis is crucial for therapeutic development.
Purpose of the Study:
- To investigate the expression and localization of phospholipase A2 isoforms (group I, II, and IV) in human and experimental acute necrotizing pancreatitis.
- To determine if the exocrine pancreas is a source of these PLA2 mediators during pancreatitis.
Main Methods:
- Northern blot analysis and immunohistochemistry were used to analyze PLA2 isoform expression and localization.
- Pancreatic tissues from 21 human acute necrotizing pancreatitis patients and rats with experimental pancreatitis were examined.
Main Results:
- Human acute pancreatitis showed decreased PLA2-I mRNA but increased PLA2-II and PLA2-IV mRNA levels.
- PLA2-IV was localized in acinar and ductal cells near necrotic areas; PLA2-II showed immunoreactivity in similar viable cells.
- In rats, PLA2-II mRNA levels increased significantly after 24 hours and fluctuated up to 7 days.
Conclusions:
- Elevated PLA2-II and PLA2-IV expression in pancreatitis indicates their role in modulating pancreatic inflammation.
- The presence of PLA2-II and PLA2-IV mRNA in viable pancreatic cells suggests the pancreas is a source of these inflammatory regulators.